Mathew Blackman
Stock Analyst at Stifel
(3.43)
# 1,003
Out of 5,112 analysts
61
Total ratings
60.47%
Success rate
15.11%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INGN Inogen | Maintains: Hold | $10 → $7 | $6.70 | +4.48% | 13 | May 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $60 → $31 | $22.03 | +40.72% | 6 | May 1, 2025 | |
| PEN Penumbra | Maintains: Buy | $301 → $318 | $315.90 | +0.66% | 2 | Apr 24, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $19 → $25 | $14.20 | +76.06% | 3 | Apr 1, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $25 | $29.25 | -14.53% | 1 | Feb 24, 2025 | |
| PODD Insulet | Maintains: Hold | $245 → $293 | $289.62 | +1.17% | 5 | Feb 21, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $94 | $87.06 | +7.97% | 5 | Feb 21, 2025 | |
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $15.46 | +55.24% | 5 | Nov 8, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $2.08 | +44.23% | 1 | Oct 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $66.06 | +51.38% | 11 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $16 | $20.01 | -20.04% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $9.96 | +10.50% | 4 | May 10, 2023 |
Inogen
May 8, 2025
Maintains: Hold
Price Target: $10 → $7
Current: $6.70
Upside: +4.48%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $60 → $31
Current: $22.03
Upside: +40.72%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $301 → $318
Current: $315.90
Upside: +0.66%
ClearPoint Neuro
Apr 1, 2025
Maintains: Buy
Price Target: $19 → $25
Current: $14.20
Upside: +76.06%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $25
Current: $29.25
Upside: -14.53%
Insulet
Feb 21, 2025
Maintains: Hold
Price Target: $245 → $293
Current: $289.62
Upside: +1.17%
Globus Medical
Feb 21, 2025
Maintains: Buy
Price Target: $92 → $94
Current: $87.06
Upside: +7.97%
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $15.46
Upside: +55.24%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $2.08
Upside: +44.23%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $66.06
Upside: +51.38%
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $20.01
Upside: -20.04%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $9.96
Upside: +10.50%